Is Parexel publicly traded?
Emily Baldwin 
EQT Private Equity and the private equity business of Goldman Sachs Asset Management announced the acquisition agreement Friday. The deal comes four years after Parexel was purchased by Pamplona Capital Management for about $5.5 billion, taking the then publicly traded CRO private.
What is Parexel?
Parexel is in the business of improving the world’s health. As a leading global clinical research organization (CRO), we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments.
Who owns Parexel International Corporation?
Pamplona Capital
Biopharmaceutical company Parexel confirmed Tuesday morning it will be acquired by Pamplona Capital for $88.10 per share in cash, in a transaction valued at approximately $5 billion.
Is Parexel for sale?
Global clinical research organization PAREXEL International has agreed to be taken over from Pamplona Capital Management for $8.5 billion.
Who is the CEO of PAREXEL?
Jamie Macdonald (Mar 15, 2018–)
Parexel/CEO
Jamie Macdonald is Chief Executive Officer of Parexel. He has nearly 25 years of experience in leading global biopharmaceutical services companies.
How much is PAREXEL worth?
The company was acquired by private equity firm Pamplona Capital Management for approximately $5.0 billion….Parexel.
| Type | Private |
|---|---|
| Revenue | $2.3 billion (2017) |
| Number of employees | 18,900 |
| Website | parexel.com |
Is PAREXEL a good company?
PAREXEL is a good company to start out at.
Who is the CEO of Parexel?
Where is parexel headquarters?
Auburndale, Newton, Massachusetts, United States
Parexel/Headquarters
How many employees does Parexel have?
18,900
Parexel/Number of employees
What is the ticker symbol of PAREXEL International?
PAREXEL International trades on the NASDAQ under the ticker symbol “PRXL.”. Media headlines about PRXL stock have trended somewhat positive on Wednesday, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources.
Who is the owner of the company Parexel?
The company was founded in 1983 and is headquartered in Waltham, Massachusetts. PAREXEL was acquired by Pamplona Capital Management on Jun 20, 2017. This deal was done in Stock.
What kind of research does PAREXEL International do?
Parexel is a global contract research organization that provides outsourced research and development services to pharmaceutical and biotechnology companies.
What is the current price of PRXL stock?
One share of PRXL stock can currently be purchased for approximately $88.08. What is 203316’s official website? Where are 203316’s headquarters? 203316 is headquartered at 195 West St, WALTHAM, MA 02451-1111, United States.
